Cargando…
Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT(1A) Receptor Case
The drug discovery and development process requires a lot of time, financial, and workforce resources. Any reduction in these burdens might benefit all stakeholders in the healthcare domain, including patients, government, and companies. One of the critical stages in drug discovery is a selection of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319483/ https://www.ncbi.nlm.nih.gov/pubmed/35890310 http://dx.doi.org/10.3390/pharmaceutics14071415 |